Alcon Inc - Company Profile
Powered by
All the data and insights you need on Alcon Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Alcon Inc Strategy Report
- Understand Alcon Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Alcon Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
22 Aug 2022 | Alcon to Acquire Aerie Pharma | Acquisition |
Alcon Inc
|
Aerie Pharmaceuticals Inc
|
24 May 2022 | Alcon Prices USD527 Million in 2.375% Senior Notes Offering Due 2028 | Debt Offering | - |
Alcon Inc |
23 May 2022 | Alcon Acquires EYSUVIS and INVELTYS from Kala Pharma | Asset Transaction |
Alcon Inc
|
Kala Pharmaceuticals Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward